Challenging the routine: evaluating the need for postoperative management in blepharoplasty: a randomized controlled trial

Keyphrases

• Randomized Controlled Trial 100%
• Postoperative Management 100%
• Upper Blepharoplasty 100%
• Blepharoplasty 100%
• Antibiotics 66%
• Topical Treatment 66%
• Ointment 66%
• Patient Satisfaction 66%
• Stony Brook Scar Evaluation Scale 66%
• No Significant Difference 33%
• Infection Risk 33%
• Antimicrobial Resistance 33%
• Lubrication 33%
• Adverse Events 33%
• No Adverse Effect 33%
• Plastic Surgeon 33%
• Aesthetic Outcome 33%
• Aesthetic Results 33%
• Multicenter Randomized Controlled Trial 33%
• Multicenter Trial 33%
• Postoperative Infection 33%
• Chloramphenicol 33%
• Conservative Management 33%
• Risk Potential 33%
• Patient-reported Outcomes 33%
• Symptom Control 33%
• Perioperative Antibiotics 33%
• Adverse Complications 33%
• Treatment Control 33%
• Aesthetic Evaluation 33%
• Conservative Care 33%
• Eyelid Swelling 33%
• Statistically Significant Difference 33%
• Topical Corticosteroids 33%
• Surgical Setting 33%
• Potential Side Effects 33%
• Steroid Ointment 33%
• Minimalist Approach 33%

Medicine and Dentistry

• Randomized Controlled Trial 100%
• Postoperative Management 100%
• Blepharoplasty 100%
• Upper Eyelid 75%
• Antimicrobial Agent 75%
• Adverse Event 50%
• Patient Satisfaction 50%
• Topical Treatment 50%
• Surgeon 25%
• Infection 25%
• Antibiotic Resistance 25%
• Postoperative Infection 25%
• Conservative Treatment 25%
• Chloramphenicol 25%
• Patient-Reported Outcome 25%
• Side Effect 25%
• Corticosteroid 25%
• Large Multicenter Trial 25%
• Dexamethasone Plus Neomycin Plus Polymyxin B 25%
• Steroid 25%

Nursing and Health Professions

• Eyelid Reconstruction 100%
• Dexamethasone Plus Neomycin Plus Polymyxin B 25%